Bispecific targeting of 4-1BB and CCR8 boosts antitumor immunity via Ti-Treg depletion and CD8+ activation

ABSTRACT:

SUBMITTER: Xu J 

PROVIDER: S-EPMC12221661 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature